US Stock MarketDetailed Quotes

OPTN OptiNose

Watchlist
  • 5.650
  • +0.300+5.61%
Close Feb 26 16:00 ET
56.81MMarket Cap-1.30P/E (TTM)

OptiNose Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OptiNose Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 17.700M--
--2024/Q4-- / 21.022M--
Nov 12, 20242024/Q320.437M / 23.003M--
Aug 8, 20242024/Q220.490M / 21.082M--
May 14, 20242024/Q114.880M / 13.667M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 17.700M--
--2024/Q4-- / 21.022M--
Nov 12, 20242024/Q320.437M / 23.003M--
Aug 8, 20242024/Q220.490M / 21.082M--
May 14, 20242024/Q114.880M / 13.667M--

Unlock Free Earnings Estimates

OptiNose Earnings Reports

  • OptiNose | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 09:36 ET

  • OptiNose | 8-K: Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights

    Nov 12, 2024 09:31 ET

  • OptiNose | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 07:19 ET

  • OptiNose | 8-K: Optinose Reports Second Quarter 2024 Financial Results and Recent Operational Highlights

    Aug 8, 2024 07:19 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +16.49%
    Hutchmed (China)
    HCM
    +6.29%
    Workday
    WDAY
    +6.22%
    DexCom
    DXCM
    +1.80%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +0.62%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 13, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data